Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021Alize J Ferrari, Masayuki Teramoto, Robert Kaba Alhassan et al.|The Lancet|2024Cited by 4.4k
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021Masayuki Teramoto, Shahzaib Ahmad, Hazim Ababneh et al.|The Lancet|2024Cited by 931
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021Masayuki Teramoto, Muayyad Ahmad, Emmanuela Gakidou et al.|The Lancet|2025Cited by 801
Exercise in Patients on Dialysis: A Multicenter, Randomized Clinical TrialFabio Manfredini, Carmine Zoccali, Pasquale Fabio Provenzano et al.|Journal of the American Society of Nephrology|2016Cited by 413
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023Masayuki Teramoto, Hassan Abolhassani, Kanyin Liane Ong et al.|The Lancet|2025Cited by 386